ArticleThe World Allergy Organization journal2021

Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life.

Diego Bagnasco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.